全文获取类型
收费全文 | 104248篇 |
免费 | 8435篇 |
国内免费 | 2179篇 |
专业分类
耳鼻咽喉 | 906篇 |
儿科学 | 2241篇 |
妇产科学 | 1450篇 |
基础医学 | 3947篇 |
口腔科学 | 4535篇 |
临床医学 | 12176篇 |
内科学 | 17435篇 |
皮肤病学 | 1575篇 |
神经病学 | 5363篇 |
特种医学 | 3314篇 |
外国民族医学 | 24篇 |
外科学 | 11650篇 |
综合类 | 17256篇 |
现状与发展 | 8篇 |
一般理论 | 4篇 |
预防医学 | 6581篇 |
眼科学 | 1624篇 |
药学 | 8876篇 |
164篇 | |
中国医学 | 8938篇 |
肿瘤学 | 6795篇 |
出版年
2024年 | 228篇 |
2023年 | 1783篇 |
2022年 | 2402篇 |
2021年 | 4295篇 |
2020年 | 4555篇 |
2019年 | 3684篇 |
2018年 | 3431篇 |
2017年 | 3745篇 |
2016年 | 4041篇 |
2015年 | 3740篇 |
2014年 | 7375篇 |
2013年 | 9455篇 |
2012年 | 6916篇 |
2011年 | 7279篇 |
2010年 | 6085篇 |
2009年 | 5381篇 |
2008年 | 4796篇 |
2007年 | 5028篇 |
2006年 | 4581篇 |
2005年 | 3903篇 |
2004年 | 3308篇 |
2003年 | 2819篇 |
2002年 | 2349篇 |
2001年 | 1916篇 |
2000年 | 1609篇 |
1999年 | 1309篇 |
1998年 | 1113篇 |
1997年 | 1009篇 |
1996年 | 832篇 |
1995年 | 719篇 |
1994年 | 702篇 |
1993年 | 600篇 |
1992年 | 474篇 |
1991年 | 421篇 |
1990年 | 294篇 |
1989年 | 316篇 |
1988年 | 290篇 |
1987年 | 256篇 |
1986年 | 227篇 |
1985年 | 287篇 |
1984年 | 223篇 |
1983年 | 153篇 |
1982年 | 197篇 |
1981年 | 160篇 |
1980年 | 137篇 |
1979年 | 120篇 |
1978年 | 72篇 |
1977年 | 64篇 |
1976年 | 55篇 |
1975年 | 31篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
《Taiwanese journal of obstetrics & gynecology》2020,59(6):865-871
ObjectiveClinical outcomes of 500 high-intensity focused ultrasound (HIFU)-treated uterine fibroids and adenomyosis are analyzed and presented.Materials and methodsThis is a retrospective cross-sectional analysis from a single tertiary medical center. From April 2015 to October 2018, 546 cases were enrolled for the study. After excluding 46 patients with less than 3 months of follow-up period, there were 404 fibroids, 149 adenomyosis and 53 mixed conditions entered for analysis. The patients’ uterine fibroids and adenomyosis were treated by HIFU according to Chongqing Haifu protocol, with 12 cm diameter transducer of focal length 10–16 cm at 0.8 or 1.6 MHz T2-weight MRI imaging was rendered prior to and 3 month post treatment to assess lesion volume change using non-perfusion volume, which was the primary outcome. Secondary outcomes including quality of life, subjective satisfaction, adverse events and pregnancy rate were determined using self-reported questionnaires. The mean follow up period ranged from 3 to 38 months with an average of 21 months.ResultsThree months after HIFU-treated uterine fibroids and adenomyosis, the lesion size reduced 40.2% and 46.3%, respectively. Symptoms all improved with better quality of life for the fibroid group, while those with adenomyosis or combined diseases benefit the most from pain control. Serum CA125 decreased significantly for all studied groups, and LDH only showed improvement for fibroids group. Number of adverse events is comparable to Chongqing data (approximately 10.2%), with mostly mild and self-resolving conditions. No permanent sequelae or death was documented. Twelve pregnancies are reported in this cohort.ConclusionHIFU is safe and effective in treating uterine fibroids and adenomyosis. The results are reproducible if standardized treatment schedules are followed. It is a promising treatment alternative with the advantages of precision, non-invasiveness, rapid recovery and readiness for pregnancy. 相似文献
92.
While once considered as incurable systemic disease, treatment options for liver metastases have increased over the last 30 years and safety has improved dramatically, such that for a selected group of patients the hope of cure can now be offered with radical treatment, and low morbidity interventions can be offered which prolong survival, even in patients with more widely disseminated disease. Advances have been made in selection and surgical technique for liver resection and several adjuncts to resection now exist in the form of portal vein embolization, thermal ablation and targeted drug or radiotherapy delivery options. A natural consequence of these developments has been the delivery of services within fewer specialist units, with the result that later complications of therapy may present to local hospitals, rather than directly to the specialist centres. This article will describe the current common liver-directed therapies and outline the presentation and management of their complications. 相似文献
93.
Prolidase deficiency is a rare autosomal recessive disorder characterized by cutaneous ulcers, facial dysmorphism, recurrent infections, and intellectual disability. We report a unique case of a 6‐year‐old boy with prolidase deficiency and Crohn's disease who presented with lower extremity ulcers. Cutaneous ulcers due to prolidase deficiency are historically resistant to treatment, and we report success with the novel use of topical tacrolimus. 相似文献
94.
95.
IntroductionCentral venous catheter applications and complications are closely related to the tip position. Previous studies have reported some rare cases of catheter misplacement. Here, we report a case of misplacement of a peripherally inserted central catheter into the lateral thoracic vein.Case reportA 56-year-old cancer patient underwent placement of a peripherally inserted central catheter through the left basilic vein under ultrasound-guided puncture. The catheterisation procedure was uneventful, so the catheter was believed to be in the superior vena cava. However, the post-anterior chest X-ray image revealed that after the catheter advanced towards the axilla, it turned downwards and outwards in the direction of the left lateral thoracic region, with the projection of the catheter tip giving the appearance of termination in the subcutaneous tissue of the lateral thoracic wall on the two-dimensional image. The catheter was then repositioned in the distal superior vena cava.DiscussionPeripherally inserted central catheters can be potentially misplaced into the lateral thoracic vein because these catheters can pass through the orifice of the lateral thoracic vein which flows into the axillary vein. Some pathological cases and clinical conditions can cause dilatation of the lateral thoracic vein, which increases the probability of catheter misplacement. Three principles were proposed to avoid this rare complication: a comprehensive review of the patients’ medical history, real-time image-guided catheterisation and routine radiographic identification of the tip position. 相似文献
96.
97.
钟晖 《中国继续医学教育》2020,(12):139-141
目的探讨紫杉醇联合卡铂化疗治疗卵巢癌的效果分析。方法选自2018年5月-2019年5月132名符合入组以及排除标准的患者,随后研究人员将患者分为对照组以及研究组,分组应按照科学、合理、随机的标准,两组患者分别均有67例,对照组患者按照研究要求,接受卡铂化疗治疗,研究组患者按照研究要求,接受紫杉醇联合卡铂化疗治疗,两组患者分别接受不同的治疗,评估患者的临床效果,对比两组患者的观察指标,如:T细胞亚群、临床疗效。结果治疗后,CD8、CD4、CD3、CD4/CD8,研究组高于对照组;研究组中,CR+PR+SD人数多于对照组患者,且治疗总有效率高于对照组患者(P<0.05)。结论紫杉醇联合卡铂化疗治疗卵巢癌,能够提升患者自身的免疫功能,促进疾病的好转。 相似文献
98.
围手术期外科之家(PSH)是一种以病人为中心的创新性围手术期管理模式,强调以医生为主导、以多学科团队为基础,基于循证医学证据,协调医疗资源,促进病人接受不同专业处理时平稳过渡,围手术期始终获得正确的处理方案,尤其适合存在器官功能障碍的外科病人。肝移植病人大多病情危重,手术复杂,围手术期管理困难。将PSH引入肝移植,可以为这类高手术风险的特殊病人群体提供一种全新的围手术期管理方式。 相似文献
99.
100.
目的探讨溃疡性结肠炎(UC)手术治疗的指征、时机、方式及转归。方法回顾性分析32例接受手术治疗的UC患者的住院病历资料,记录患者的临床表现、诊疗过程、手术方式及转归,并对患者术后情况进行随访。结果 71.9%(23/32)手术病例为重型UC;初发型占21.9%(7/32),慢性复发型78.1%(25/32);广泛结肠病变占93.8%(30/32),其中全结肠受累占81.3%(26/32)。手术原因:药物治疗不能达到或维持缓解26例(81.3%);UC相关结直肠癌(UC-CRC)/上皮内瘤变(IEN)5例(15.6%);并发肠穿孔1例(3.1%)。手术方式:全结直肠切除、回肠储袋肛管吻合术(IPAA)19例(59.4%),回肠永久造瘘术或长期保留造瘘口7例(21.9%),全结肠或次全结肠切除、肠吻合术6例(18.8%)。术后并发症发生率69.6%(16/23),分别为肠梗阻9例、吻合口狭窄2例、盆腔感染2例、直肠阴道瘘1例、切口疝1例、储袋炎2例、残余直肠UC复发2例。25例(78.1%)患者接受随访2个月~22年,21例UC治愈,2例因残余直肠UC复发继续药物治疗,2例因UC-CRC广泛转移死亡。结论手术是药物难治性及出现并发症UC的治疗选择,多数患者手术效果满意,术后并发症发生率较高,手术时机、术式及术后并发症的预防及随访有待进一步规范。 相似文献